DUAC® Early Onset Efficacy Study in Japanese Subjects

NCT02557399 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

350

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: Duac® fixed dose combination gel
DRUG: ADA 0.1% gel
DRUG: CLDM 1% gel

Sponsor

GlaxoSmithKline